Surgery for Metastatic Renal Cell Cancer

Surgery and immunotherapy are the cornerstones of current treatment for metastatic kidney cancer. While immunotherapy has been on the front-lines of cancer research and widely touted as a breakthrough, surgery is seen as old hat and never makes the headlines. Although surgery is underappreciated, its importance should not be underestimated. Many are unaware of how much the limits of when surgery alone can be useful have expanded over time as surgeons have pushed the frontier. Surgery can also be combined in various ways with immunotherapy, and I believe that the combination may be responsible for 30 to 50% of the long term survivals attributed to immunotherapy.

CancerGuide has three major articles on this important subject:

  • Surgery for Metastatic Renal Cell Cancer by Steve Dunn
    This article is about surgery alone as treatment for metastatic RCC.
  • Combining Surgery With Immunotherapy by Steve Dunn
    This article is about surgery combined with immunotherapy as treatment for metastatic RCC.
  • Notes on the Potential for Metastasectomy in RCC by Mike Fischer (PDF File Will Open in New Window)
    This article covers both surgery alone and surgery combined with immunotherapy. It is more technical than my articles and covers more papers but in a little less detail.
    Mike Fischer is a major benefactor of CancerGuide, member of our KIDNEY-ONC mailing list, and reader of the technical literature extraordinare. Note: Mike’s article is a PDF file – if you have trouble reading it, get the free ACROBAT reader from Adobe here: Get Acrobat

This CancerGuide Page By Steve Dunn. © Steve Dunn
Page Created: May 6, 2002, Last Updated: September 26, 2003